Morning Overview on MSN
Researchers find some cancer drugs work differently than their stated targets
As of spring 2026, a cancer drug that has spent years in clinical development as a Wnt/beta-catenin pathway blocker has been ...
The results are transforming how scholars understand human history. By analysing parchment, researchers are uncovering ...
BACKGROUND: Preeclampsia affects approximately 1 in 10 pregnancies, leading to severe complications and long-term health ...
Background Neutrophils guarantee a prompt and robust host response to pathogens. Yet, overshooting neutrophil activation ...
BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...
HHMI researchers have developed an in vivo proteomic method for identifying proteins in the BBB that may regulate access through vessels.
Scientists created a definitive E3 ligase atlas, resolving inconsistencies and enabling better disease research and drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results